Evidence-based practice tutorial – Critical Appraisal Skills
... Randomised controlled trials (RCTs) Randomised controlled trials are described as the “gold standard” in medical research. They are suitable for testing interventions concerned with treatment or prevention, but give no information about the context of a trial or the patients’ experience of treatment ...
... Randomised controlled trials (RCTs) Randomised controlled trials are described as the “gold standard” in medical research. They are suitable for testing interventions concerned with treatment or prevention, but give no information about the context of a trial or the patients’ experience of treatment ...
Constipation - Gloucestershire Hospitals NHS Foundation Trust
... Bulk forming laxatives are useful when dietary fibre is inadequate but should be avoided if fluid intake is poor . Osmotic laxatives are useful as they draw water into the gut softening the stool without increasing peristalsis. Softeners can be useful and are often used in conjunction with a stimula ...
... Bulk forming laxatives are useful when dietary fibre is inadequate but should be avoided if fluid intake is poor . Osmotic laxatives are useful as they draw water into the gut softening the stool without increasing peristalsis. Softeners can be useful and are often used in conjunction with a stimula ...
Osteopathic Principles in Infectious Disease
... The hairs in the nares filter particulate matter Some infecting agents and particulate matter is captured in mucous, mixed with saliva and swallowed for destruction in the acid environment of the stomach The cilia act as an “escalator” and deliver some foreign components back to the oropharynx There ...
... The hairs in the nares filter particulate matter Some infecting agents and particulate matter is captured in mucous, mixed with saliva and swallowed for destruction in the acid environment of the stomach The cilia act as an “escalator” and deliver some foreign components back to the oropharynx There ...
Immune-Strategies-for-HIV-Prevention_ARD-2015_LSC - UZ-UCSF
... Potent and broadly neutralizing monoclonal antibodies provide a new opportunity for HIV prevention (also treatment / cure) If effective, antibody production can be scaled up and altered to increase duration of effect (> 1 month) ...
... Potent and broadly neutralizing monoclonal antibodies provide a new opportunity for HIV prevention (also treatment / cure) If effective, antibody production can be scaled up and altered to increase duration of effect (> 1 month) ...
Synopsis - PLoS ONE
... Chronic hepatitis C virus (HCV) infection infection and nonalcoholic fatty liver disease (NAFLD) are characterized by a spectrum of pathological conditions ranging from an early stage of inflammation and fibrosis up to more advanced disease conditions, such as hepatocellular carcinoma. The prevalenc ...
... Chronic hepatitis C virus (HCV) infection infection and nonalcoholic fatty liver disease (NAFLD) are characterized by a spectrum of pathological conditions ranging from an early stage of inflammation and fibrosis up to more advanced disease conditions, such as hepatocellular carcinoma. The prevalenc ...
Auditory Alterations
... system affected • Population at risk: - usually first occurs in people aged 20 – 50 yrs old -more common in men and in white people • S & S: three main features -Tinnitus - one-sided sensorineural hearing loss - vertigo ...
... system affected • Population at risk: - usually first occurs in people aged 20 – 50 yrs old -more common in men and in white people • S & S: three main features -Tinnitus - one-sided sensorineural hearing loss - vertigo ...
Characteristics of systemic sclerosis patients in Nairobi, Kenya : a
... tertiary referral and teaching hospital situated in Nairobi, Kenya; and is one of two in the country. It is the only public hospital with a rheumatology clinic, which has been in operation for one year, having been started in February 2010. Prior to the inauguration of this clinic, patients were see ...
... tertiary referral and teaching hospital situated in Nairobi, Kenya; and is one of two in the country. It is the only public hospital with a rheumatology clinic, which has been in operation for one year, having been started in February 2010. Prior to the inauguration of this clinic, patients were see ...
Comparison of pharmacokinetics and efficacy of oral and injectable
... administration of drugs in terms of pharmacokinetics • IV administration results in shorter onset of action and for some drugs higher bioavailability and peak serum levels • The issue of onset of action is clinically relevant only in life threatening illness ...
... administration of drugs in terms of pharmacokinetics • IV administration results in shorter onset of action and for some drugs higher bioavailability and peak serum levels • The issue of onset of action is clinically relevant only in life threatening illness ...
The challenge of multiple sclerosis: How do we cure a chronic
... D–related type 2 (HLA-DR2) dose effect may be associated with a more severe form of the disease.61 Multiple Sclerosis Biomarkers Magnetic Resonance Imaging A major tool to address the heterogeneity of MS and devise appropriate treatment strategies is to develop reliable biomarkers. MRI has served as ...
... D–related type 2 (HLA-DR2) dose effect may be associated with a more severe form of the disease.61 Multiple Sclerosis Biomarkers Magnetic Resonance Imaging A major tool to address the heterogeneity of MS and devise appropriate treatment strategies is to develop reliable biomarkers. MRI has served as ...
A booklet about Multiple Sclerosis for family members
... unwilling to make the diagnosis of MS until there is good evidence for multiple lesions. While this may lead to long periods of uncertainty for both patient and physician about what the symptoms mean, most people will agree that it is best to be sure of the diagnosis before making it. WHAT HAPPENS ...
... unwilling to make the diagnosis of MS until there is good evidence for multiple lesions. While this may lead to long periods of uncertainty for both patient and physician about what the symptoms mean, most people will agree that it is best to be sure of the diagnosis before making it. WHAT HAPPENS ...
Pharma/biotech companies do better job than most providing career
... endorsed joint Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers. “Biopharmaceutical companies commit to enhance these efforts by making additional information available to the public, patients who participate in clinical trials and to qualified resea ...
... endorsed joint Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers. “Biopharmaceutical companies commit to enhance these efforts by making additional information available to the public, patients who participate in clinical trials and to qualified resea ...
than just a definition of Stiff Person Syndrome
... spasms. Usually, it begins in the axial muscles and extends to the proximal limb muscles, but the severity of the limb muscle involvement may overwhelm the axial muscle involvement (stiff limb syndrome). Some confusion has occurred as a result of cases that include other neurologic findings, such as ...
... spasms. Usually, it begins in the axial muscles and extends to the proximal limb muscles, but the severity of the limb muscle involvement may overwhelm the axial muscle involvement (stiff limb syndrome). Some confusion has occurred as a result of cases that include other neurologic findings, such as ...
Vulnerable Populations - OPRS Office for the Protection of Research
... epilepsy – an adverse event not seen in studies on adults; and this drug has to be given at a higher-than-expected dose to be effective in kids under the age of five. ...
... epilepsy – an adverse event not seen in studies on adults; and this drug has to be given at a higher-than-expected dose to be effective in kids under the age of five. ...
leukemia - Emerson Statistics Home
... Treatments which show promising anti-cancer activity at tolerable doses are then tested in a larger Phase III trial. Such trials usually have as their goal the comparison of the new treatment to some existing standard treatment or, if no standard therapy exists, to a placebo. Whenever possible, thes ...
... Treatments which show promising anti-cancer activity at tolerable doses are then tested in a larger Phase III trial. Such trials usually have as their goal the comparison of the new treatment to some existing standard treatment or, if no standard therapy exists, to a placebo. Whenever possible, thes ...
Faculty of Infectious and Tropical Diseases
... anthropologists and social scientists, clinical scientists, public health engineers and geographers. This range of expertise provides us with a battery of tools for focusing on the control of diseases that are insect-borne, water-borne or associated with poor hygiene – mostly in developing countries ...
... anthropologists and social scientists, clinical scientists, public health engineers and geographers. This range of expertise provides us with a battery of tools for focusing on the control of diseases that are insect-borne, water-borne or associated with poor hygiene – mostly in developing countries ...
Inflammatory Bowel Disease 2016 What`s In The Pipeline?
... • Level of target may be influenced by comorbidities and drugrelated risks • Desired target should be maintained indefinitely • Use both symptoms and objective measures of inflammation (endoscopic or radiologic) to guide treatment decisions • Assess mucosal healing every 6 months till target is achi ...
... • Level of target may be influenced by comorbidities and drugrelated risks • Desired target should be maintained indefinitely • Use both symptoms and objective measures of inflammation (endoscopic or radiologic) to guide treatment decisions • Assess mucosal healing every 6 months till target is achi ...
Did the world wide amphibian emerging infectious disease originate
... this area come to live robustly with this fungus? Can we use this knowledge to efficiently protect other species worldwide? How can we control further disease spread? How do some species survive with infection while others do not? How does this particular microbe interact as a skin disease? Does it ...
... this area come to live robustly with this fungus? Can we use this knowledge to efficiently protect other species worldwide? How can we control further disease spread? How do some species survive with infection while others do not? How does this particular microbe interact as a skin disease? Does it ...
Untitled - Immanuel College
... from holiday he realised a sample of new germs had settled on the petri dish and killed the germs – Penicillin had been ...
... from holiday he realised a sample of new germs had settled on the petri dish and killed the germs – Penicillin had been ...
Haemophilus Influenzae Type B (Hib, H flu)
... sometimes after they appear to be well. After one to two days of treatment an infected person can no longer spread the disease. What is the treatment for Hib disease? Antibiotics are used to treat serious infections. Should people exposed to an infected person be treated? Household members, day-care ...
... sometimes after they appear to be well. After one to two days of treatment an infected person can no longer spread the disease. What is the treatment for Hib disease? Antibiotics are used to treat serious infections. Should people exposed to an infected person be treated? Household members, day-care ...
Preceyes supports targeted drug delivery in the eye
... suffered a retinal bleed. The operation was performed successfully under local anaesthetic without any complications. It is still early days, but we hope this milestone brings us closer to our eventual goal of using robotic surgery to deliver gene therapy and stem cell treatments for currently incur ...
... suffered a retinal bleed. The operation was performed successfully under local anaesthetic without any complications. It is still early days, but we hope this milestone brings us closer to our eventual goal of using robotic surgery to deliver gene therapy and stem cell treatments for currently incur ...
Questions to ask when choosing antibiotics?
... To achieve additive effects on resistant infections (e.g., PVE, H. pylori) To treat multiple phases (forms) of the same pathogen (e.g., TB, parasitic diseases) When a single antibiotic would have to be given in toxic doses ...
... To achieve additive effects on resistant infections (e.g., PVE, H. pylori) To treat multiple phases (forms) of the same pathogen (e.g., TB, parasitic diseases) When a single antibiotic would have to be given in toxic doses ...
Launch of the Agent for Osteoporosis “Bonviva® Tablet 100 mg”
... Insurance (NHI) reimbursement price list on April 20, 2016. The efficacy of Bonviva Tablet of once a month administration has been confirmed in a phase III study using ibandronate sodium hydrate injection [brand name: Bonviva® IV Injection 1 mg Syringe (Bonviva IV Injection)] as a control (The MOVES ...
... Insurance (NHI) reimbursement price list on April 20, 2016. The efficacy of Bonviva Tablet of once a month administration has been confirmed in a phase III study using ibandronate sodium hydrate injection [brand name: Bonviva® IV Injection 1 mg Syringe (Bonviva IV Injection)] as a control (The MOVES ...